世界の非侵襲的出生前診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Noninvasive Prenatal Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4175
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、非侵襲的出生前診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（サービス、器具）、用途別市場規模（病院、個人、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・非侵襲的出生前診断の市場動向
・企業の競争状況、市場シェア
・非侵襲的出生前診断の種類別市場規模（サービス、器具）
・非侵襲的出生前診断の用途別市場規模（病院、個人、その他）
・非侵襲的出生前診断の北米市場規模2016-2027（アメリカ、カナダ）
・非侵襲的出生前診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・非侵襲的出生前診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・非侵襲的出生前診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・非侵襲的出生前診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Natera、Illumina、BGI Diagnosis、Ariosa Diagnostics、Quest Diagnostics、Premaitha Health、NIPD Genetics、Labcorp、Ravgen、LifeCodexx、TrovaGene、Quest Diagnostics、Berry Genomics）
・結論

Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down’s syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.
North America has the largest share of the noninvasive prenatal diagnostics market, with Asia Pacific and the Middle East achieving the fastest growth.

Market Analysis and Insights: Global Noninvasive Prenatal Diagnostics Market
The global Noninvasive Prenatal Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Noninvasive Prenatal Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Noninvasive Prenatal Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Noninvasive Prenatal Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Noninvasive Prenatal Diagnostics market.

Global Noninvasive Prenatal Diagnostics Scope and Market Size
Noninvasive Prenatal Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Noninvasive Prenatal Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Services
Instrument

Segment by Application
Hospital
Personal
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Natera
Illumina
BGI Diagnosis
Ariosa Diagnostics
Quest Diagnostics
Premaitha Health
NIPD Genetics
Labcorp
Ravgen
Ariosa Diagnostics
Quest Diagnostics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Services
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Noninvasive Prenatal Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Personal
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Noninvasive Prenatal Diagnostics Market Perspective (2016-2027)
2.2 Noninvasive Prenatal Diagnostics Growth Trends by Regions
2.2.1 Noninvasive Prenatal Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Noninvasive Prenatal Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Noninvasive Prenatal Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Noninvasive Prenatal Diagnostics Industry Dynamic
2.3.1 Noninvasive Prenatal Diagnostics Market Trends
2.3.2 Noninvasive Prenatal Diagnostics Market Drivers
2.3.3 Noninvasive Prenatal Diagnostics Market Challenges
2.3.4 Noninvasive Prenatal Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Prenatal Diagnostics Players by Revenue
3.1.1 Global Top Noninvasive Prenatal Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Noninvasive Prenatal Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Noninvasive Prenatal Diagnostics Revenue
3.4 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio
3.4.1 Global Noninvasive Prenatal Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Prenatal Diagnostics Revenue in 2020
3.5 Noninvasive Prenatal Diagnostics Key Players Head office and Area Served
3.6 Key Players Noninvasive Prenatal Diagnostics Product Solution and Service
3.7 Date of Enter into Noninvasive Prenatal Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Noninvasive Prenatal Diagnostics Breakdown Data by Type
4.1 Global Noninvasive Prenatal Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Type (2022-2027)

5 Noninvasive Prenatal Diagnostics Breakdown Data by Application
5.1 Global Noninvasive Prenatal Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Noninvasive Prenatal Diagnostics Market Size (2016-2027)
6.2 North America Noninvasive Prenatal Diagnostics Market Size by Type
6.2.1 North America Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Noninvasive Prenatal Diagnostics Market Size by Type (2016-2027)
6.3 North America Noninvasive Prenatal Diagnostics Market Size by Application
6.3.1 North America Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Noninvasive Prenatal Diagnostics Market Size by Application (2016-2027)
6.4 North America Noninvasive Prenatal Diagnostics Market Size by Country
6.4.1 North America Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Noninvasive Prenatal Diagnostics Market Size (2016-2027)
7.2 Europe Noninvasive Prenatal Diagnostics Market Size by Type
7.2.1 Europe Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Noninvasive Prenatal Diagnostics Market Size by Type (2016-2027)
7.3 Europe Noninvasive Prenatal Diagnostics Market Size by Application
7.3.1 Europe Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Noninvasive Prenatal Diagnostics Market Size by Application (2016-2027)
7.4 Europe Noninvasive Prenatal Diagnostics Market Size by Country
7.4.1 Europe Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type
8.2.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application
8.3.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region
8.4.1 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Noninvasive Prenatal Diagnostics Market Size (2016-2027)
9.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Type
9.2.1 Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Noninvasive Prenatal Diagnostics Market Size by Application
9.3.1 Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Noninvasive Prenatal Diagnostics Market Size by Country
9.4.1 Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type
10.2.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application
10.3.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country
10.4.1 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Natera
11.1.1 Natera Company Details
11.1.2 Natera Business Overview
11.1.3 Natera Noninvasive Prenatal Diagnostics Introduction
11.1.4 Natera Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.1.5 Natera Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Noninvasive Prenatal Diagnostics Introduction
11.2.4 Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.2.5 Illumina Recent Development
11.3 BGI Diagnosis
11.3.1 BGI Diagnosis Company Details
11.3.2 BGI Diagnosis Business Overview
11.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Introduction
11.3.4 BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.3.5 BGI Diagnosis Recent Development
11.4 Ariosa Diagnostics
11.4.1 Ariosa Diagnostics Company Details
11.4.2 Ariosa Diagnostics Business Overview
11.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Introduction
11.4.4 Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.4.5 Ariosa Diagnostics Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Details
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
11.5.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.5.5 Quest Diagnostics Recent Development
11.6 Premaitha Health
11.6.1 Premaitha Health Company Details
11.6.2 Premaitha Health Business Overview
11.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Introduction
11.6.4 Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.6.5 Premaitha Health Recent Development
11.7 NIPD Genetics
11.7.1 NIPD Genetics Company Details
11.7.2 NIPD Genetics Business Overview
11.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Introduction
11.7.4 NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.7.5 NIPD Genetics Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Noninvasive Prenatal Diagnostics Introduction
11.8.4 Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.8.5 Labcorp Recent Development
11.9 Ravgen
11.9.1 Ravgen Company Details
11.9.2 Ravgen Business Overview
11.9.3 Ravgen Noninvasive Prenatal Diagnostics Introduction
11.9.4 Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.9.5 Ravgen Recent Development
11.10 LifeCodexx
11.10.1 LifeCodexx Company Details
11.10.2 LifeCodexx Business Overview
11.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Introduction
11.10.4 LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.10.5 LifeCodexx Recent Development
11.11 TrovaGene
11.11.1 TrovaGene Company Details
11.11.2 TrovaGene Business Overview
11.11.3 TrovaGene Noninvasive Prenatal Diagnostics Introduction
11.11.4 TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.11.5 TrovaGene Recent Development
11.12 Quest Diagnostics
11.12.1 Quest Diagnostics Company Details
11.12.2 Quest Diagnostics Business Overview
11.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Introduction
11.12.4 Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.12.5 Quest Diagnostics Recent Development
11.13 Berry Genomics
11.13.1 Berry Genomics Company Details
11.13.2 Berry Genomics Business Overview
11.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Introduction
11.13.4 Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021)
11.13.5 Berry Genomics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Noninvasive Prenatal Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Services
Table 3. Key Players of Instrument
Table 4. Global Noninvasive Prenatal Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Noninvasive Prenatal Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Noninvasive Prenatal Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Noninvasive Prenatal Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Noninvasive Prenatal Diagnostics Market Share by Regions (2022-2027)
Table 10. Noninvasive Prenatal Diagnostics Market Trends
Table 11. Noninvasive Prenatal Diagnostics Market Drivers
Table 12. Noninvasive Prenatal Diagnostics Market Challenges
Table 13. Noninvasive Prenatal Diagnostics Market Restraints
Table 14. Global Noninvasive Prenatal Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Noninvasive Prenatal Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Noninvasive Prenatal Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Prenatal Diagnostics as of 2020)
Table 17. Ranking of Global Top Noninvasive Prenatal Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Noninvasive Prenatal Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Noninvasive Prenatal Diagnostics Product Solution and Service
Table 21. Date of Enter into Noninvasive Prenatal Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Noninvasive Prenatal Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Noninvasive Prenatal Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Natera Company Details
Table 62. Natera Business Overview
Table 63. Natera Noninvasive Prenatal Diagnostics Product
Table 64. Natera Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Natera Recent Development
Table 66. Illumina Company Details
Table 67. Illumina Business Overview
Table 68. Illumina Noninvasive Prenatal Diagnostics Product
Table 69. Illumina Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Illumina Recent Development
Table 71. BGI Diagnosis Company Details
Table 72. BGI Diagnosis Business Overview
Table 73. BGI Diagnosis Noninvasive Prenatal Diagnostics Product
Table 74. BGI Diagnosis Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 75. BGI Diagnosis Recent Development
Table 76. Ariosa Diagnostics Company Details
Table 77. Ariosa Diagnostics Business Overview
Table 78. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product
Table 79. Ariosa Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Ariosa Diagnostics Recent Development
Table 81. Quest Diagnostics Company Details
Table 82. Quest Diagnostics Business Overview
Table 83. Quest Diagnostics Noninvasive Prenatal Diagnostics Product
Table 84. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Quest Diagnostics Recent Development
Table 86. Premaitha Health Company Details
Table 87. Premaitha Health Business Overview
Table 88. Premaitha Health Noninvasive Prenatal Diagnostics Product
Table 89. Premaitha Health Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Premaitha Health Recent Development
Table 91. NIPD Genetics Company Details
Table 92. NIPD Genetics Business Overview
Table 93. NIPD Genetics Noninvasive Prenatal Diagnostics Product
Table 94. NIPD Genetics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 95. NIPD Genetics Recent Development
Table 96. Labcorp Company Details
Table 97. Labcorp Business Overview
Table 98. Labcorp Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Labcorp Recent Development
Table 100. Ravgen Company Details
Table 101. Ravgen Business Overview
Table 102. Ravgen Noninvasive Prenatal Diagnostics Product
Table 103. Ravgen Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 104. Ravgen Recent Development
Table 105. LifeCodexx Company Details
Table 106. LifeCodexx Business Overview
Table 107. LifeCodexx Noninvasive Prenatal Diagnostics Product
Table 108. LifeCodexx Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 109. LifeCodexx Recent Development
Table 110. TrovaGene Company Details
Table 111. TrovaGene Business Overview
Table 112. TrovaGene Noninvasive Prenatal Diagnostics Product
Table 113. TrovaGene Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 114. TrovaGene Recent Development
Table 115. Quest Diagnostics Company Details
Table 116. Quest Diagnostics Business Overview
Table 117. Quest Diagnostics Noninvasive Prenatal Diagnostics Product
Table 118. Quest Diagnostics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 119. Quest Diagnostics Recent Development
Table 120. Berry Genomics Company Details
Table 121. Berry Genomics Business Overview
Table 122. Berry Genomics Noninvasive Prenatal Diagnostics Product
Table 123. Berry Genomics Revenue in Noninvasive Prenatal Diagnostics Business (2016-2021) & (US$ Million)
Table 124. Berry Genomics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Prenatal Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Services Features
Figure 3. Instrument Features
Figure 4. Global Noninvasive Prenatal Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Personal Case Studies
Figure 7. Other Case Studies
Figure 8. Noninvasive Prenatal Diagnostics Report Years Considered
Figure 9. Global Noninvasive Prenatal Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Noninvasive Prenatal Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Noninvasive Prenatal Diagnostics Market Share by Regions: 2020 VS 2027
Figure 12. Global Noninvasive Prenatal Diagnostics Market Share by Regions (2022-2027)
Figure 13. Global Noninvasive Prenatal Diagnostics Market Share by Players in 2020
Figure 14. Global Top Noninvasive Prenatal Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Noninvasive Prenatal Diagnostics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Noninvasive Prenatal Diagnostics Revenue in 2020
Figure 16. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type (2016-2021)
Figure 17. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type (2022-2027)
Figure 18. North America Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Noninvasive Prenatal Diagnostics Market Share by Type (2016-2027)
Figure 20. North America Noninvasive Prenatal Diagnostics Market Share by Application (2016-2027)
Figure 21. North America Noninvasive Prenatal Diagnostics Market Share by Country (2016-2027)
Figure 22. United States Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Noninvasive Prenatal Diagnostics Market Share by Type (2016-2027)
Figure 26. Europe Noninvasive Prenatal Diagnostics Market Share by Application (2016-2027)
Figure 27. Europe Noninvasive Prenatal Diagnostics Market Share by Country (2016-2027)
Figure 28. Germany Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Noninvasive Prenatal Diagnostics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Noninvasive Prenatal Diagnostics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Noninvasive Prenatal Diagnostics Market Share by Region (2016-2027)
Figure 38. China Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Noninvasive Prenatal Diagnostics Market Share by Type (2016-2027)
Figure 46. Latin America Noninvasive Prenatal Diagnostics Market Share by Application (2016-2027)
Figure 47. Latin America Noninvasive Prenatal Diagnostics Market Share by Country (2016-2027)
Figure 48. Mexico Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Noninvasive Prenatal Diagnostics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Noninvasive Prenatal Diagnostics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Noninvasive Prenatal Diagnostics Market Share by Country (2016-2027)
Figure 54. Turkey Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Noninvasive Prenatal Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Natera Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 58. Illumina Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 59. BGI Diagnosis Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 60. Ariosa Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 61. Quest Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 62. Premaitha Health Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 63. NIPD Genetics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 64. Labcorp Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 65. Ravgen Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 66. LifeCodexx Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 67. TrovaGene Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 68. Quest Diagnostics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 69. Berry Genomics Revenue Growth Rate in Noninvasive Prenatal Diagnostics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の非侵襲的癌診断市場規模・現状・予測（2021年-2027年）

Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z4171 2021年4月 96Pages
QYResearch社発行の本調査資料では、非侵襲的癌診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別市場規模（固形がん、血液がん、肺がん、乳がん、その他）、主要地域別市場規模（...

世界の出生前検査市場規模・現状・予測（2021年-2027年）

Global Prenatal Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4775 2021年4月 91Pages
QYResearch社発行の本調査資料では、出生前検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（第1期スクリーニング検査、第2期スクリーニング検査、第3期スクリーニング検査、診断検査）、用途別市場規模（病院、病理学研究室、婦人科クリニック...

世界の非侵襲的出生前検査市場規模・現状・予測（2021年-2027年）

Global Non-Invasive Prenatal Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4177 2021年4月 91Pages
QYResearch社発行の本調査資料では、非侵襲的出生前検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（高リスク＆平均リスク、低リスク）、用途別市場規模（0〜12週間、13〜24週間、25〜36週間）、主要地域別市場規模（北米、アメリカ、...

世界の出生前遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Prenatal Genetic Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4774 2021年4月 95Pages
QYResearch社発行の本調査資料では、出生前遺伝子検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（診断検査、絨毛膜絨毛サンプリング（CVS）、羊水穿刺、胎盤生検、臍帯穿刺、胎児生検、スクリーニング検査、キャリアスクリーニング、順次スク...

世界の出生前＆新生児遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Prenatal and Newborn Genetic Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4773 2021年4月 126Pages
QYResearch社発行の本調査資料では、出生前＆新生児遺伝子検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アレイ比較遺伝子ハイブリダイゼーション（aCGH）、蛍光in-situハイブリダイゼーション（FISH）、ポリメラーゼ連鎖反応（...

世界の出生前＆新生児遺伝子検査市場規模・現状・予測（2021年-2027年）

世界の非侵襲的温度管理システム市場規模・現状・予測（2021年-2027年）

Global Noninvasive Temperature Management System Market Size, Status and Forecast 2021-2027
QYR2104Z4179 2021年4月 96Pages
QYResearch社発行の本調査資料では、非侵襲的温度管理システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（患者冷却システム、患者加温システム）、用途別市場規模（周術期ケア、急性期ケア、新生児ケア、その他）、主要地域別市場規模（北米、ア...

世界の非侵襲的外科的創閉鎖法市場規模・現状・予測（2021年-2027年）

Global Noninvasive Surgical Wound Closure Market Size, Status and Forecast 2021-2027
QYR2104Z4178 2021年4月 131Pages
QYResearch社発行の本調査資料では、非侵襲的外科的創閉鎖法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（接着剤、止血剤）、用途別市場規模（産科、婦人科、整形外科、化粧品、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の非侵襲的がん診断市場 2021：企業別、地域別、種類・用途別

Global Noninvasive Cancer Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z10044 2021年4月 100Pages
当調査資料では、非侵襲的がん診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。非侵襲的がん診断の種類別市場規模（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別市場規模（固形腫瘍、血液がん、肺がん、乳がん、その他）、地域別市場規模（北米...

世界の非侵襲的出生前検査（NIPT）市場規模・現状・予測（2021年-2027年）

Global Non-Invasive Prenatal Testing (NIPT) Market Size, Status and Forecast 2021-2027
QYR2104Z4176 2021年4月 99Pages
QYResearch社発行の本調査資料では、非侵襲的出生前検査（NIPT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（超音波、NGS、PCR、マイクロアレイ）、用途別市場規模（病院、診断ラボ）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の非侵襲的癌診断市場規模・現状・予測（2021年-2027年） Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to gen…
世界の出生前検査市場規模・現状・予測（2021年-2027年） Prenatal testing consists of prenatal screening and prenatal diagnosis, which are aspects of prenatal care that focus on detecting problems with the pregnancy as early as possible. Prenatal screening can detect problems such as neural tube defects, chromosome abnormalities, and it can also detect an…
世界の非侵襲的がん診断市場 2021：企業別、地域別、種類・用途別 The Noninvasive Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
世界の非侵襲的出生前検査市場規模・現状・予測（2021年-2027年） Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood Market Analysis and Insights: Global Non-Invasive Prenatal Testing Market Th…
世界の出生前遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …